Cancer Therapeutics

 

67 Organization(s)

Adaptimmune

Business Area(s): 
Description: 

Revolutionizing cancer therapy on a global basis by developing TCR therapies with the potential to treat a wide range of cancer types and patients.

Adheren

Business Area(s): 
Description: 

Cancer immunotherapy

Admune Therapeutics

Business Area(s): 
Description: 

Cancer immunotherapy

Aduro Biotech

Business Area(s): 
Description: 

Aduro’s three proprietary technology platforms (Live, Attenuated Double-Deleted Listeria (LADD), STING Pathway Activators, and B-select monoclonal antibodies) have the potential to transform the ...

Advaxis

Business Area(s): 
Description: 

Advaxis’ Lm Technology uses live, attenuated bioengineered Listeria monocytogenes (Lm) bacteria to stimulate the immune system to view tumor cells as potentially ...

Alpine Immune Sciences

Business Area(s): 
Description: 

The company creates protein-based immunotherapies to treat cancer, autoimmune disorders, and other diseases.

Amgen

Business Area(s): 
Description: 

Biologics.  Amgen makes several therapeutic drugs that target serious disease.  Many are derived from engineered monoclonal antibodies.  Some target immune receptors.

Aminex Therapeutics

Business Area(s): 
Description: 

Aminex Therapeutics, Inc., is a drug development company focused on discovery and development of a unique cancer drug therapy in the general category of cancer immunotherapies known as checkpoint ...

ApoGen Biotech

Business Area(s): 
Description: 

Aptevo Therapeutics

Business Area(s): 
Description: 

Uses modified antibodies to generate immunotherapeutics.

ARIZ Biopharma

Business Area(s): 
Description: 

Developing PRDM Gene and Protein Modulation Agents as Anti-Cancer Products

Atara Bio

Business Area(s): 
Description: 

Atara Bio’s programs include T-cell product candidates and molecularly-targeted product candidates.

Atossa Genetics

Business Area(s): 
Description: 

Atossa Genetics is a clinical-stage pharmaceutical company focused on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.

AVM Biotechnology

Business Area(s): 
Description: 

Stem Cell Technologies, Fully Human Biologics Manufacturing Cell Lines, Regenerative Medicine, CAR-T Immunotherapy & Cancer Treatment.

BeiGene

Business Area(s): 
Description: 

A biopharmaceutical company dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer.

Bellicum Pharmaceuticals

Business Area(s): 
Description: 

Develops next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT), CAR T cell therapy, and TCR ...

Bicycle Therapeutics

Business Area(s): 
Description: 

Bicycles are a new therapeutic modality combining the attributes of antibodies, small molecules and peptides within one molecule. Bicycles exhibit the affinity and selective ...

Blaze Bioscience

Business Area(s): 
Description: 

Real-time cancer cell visualization for surgical applications. Blaze is working to develop Tumor Paint products and Optide*-based guided therapeutics.

bluebird bio

Business Area(s): 
Description: 

The cancer immunotherapy research group is focused on the next generation of T cell engineering and creating a pipeline of T cell product candidates (CAR T cells) to treat a wide variety of liquid ...

Bristol-Meyers Squibb

Business Area(s): 
Description: 

A biopharmaceutical company.  They discover, develop, and deliver medicines to treat serious disease.

Cascadian Therapeutics

Business Area(s): 
Description: 

Develops novel compounds for cancer treatment. The most advanced product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor. 

Celldex Therapeutics

Business Area(s): 
Description: 

Small Molecules, Biologics, Vaccines, The pipeline is comprised of antibody-based therapies and other protein-based therapeutics that modulate the immune system or directly target tumors. ...

Cellectis

Business Area(s): 
Description: 

Designing next generation immunotherapies based on gene-edited CAR T-cells

Checkmate Pharma

Business Area(s): 
Description: 

Develops technology to activate the innate and adaptive arms of the immune system to recognize and ultimately destroy tumor cells.

CisThera

Business Area(s): 
Description: 

CisThera’s mission is to develop innovative therapeutics to treat  cancer, autoimmune diseases, as well as chronic kidney and liver diseases.

Cleveland Biolabs

Business Area(s): 
Description: 

Develops molecules to activate Toll like receptors.  These can be used to stimulate the innate immune system.  

Compliment Corporation

Business Area(s): 
Description: 

Compliment Corporation is a start-up biotechnology company developing revolutionary therapeutics in oncology.  Our mission is to improve cancer treatment by dramatically increasing the ...

Corvus Pharmaceuticals

Business Area(s): 
Description: 

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel agents that target the immune system to treat patients with cancer. 

CTI BioPharma

Business Area(s): 
Description: 

CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers

Curis

Business Area(s): 
Description: 

Develops anti-cancer drugs.

CytomX Therapeutics

Business Area(s): 
Description: 

Develops cancer immunotherapies, drug conjugates (PDCs), T-cell engaging Probody bispecifics and ProCAR-NK cell therapies based on Protease-Activated Antibodies, 'Probodies'

Dendreon

Business Area(s): 
Description: 

Immunotherapy treatment for prostate cancer.

FivePrime

Business Area(s): 
Description: 

Focused on therapies for cancer and inflammatory diseases

FLX Bio

Business Area(s): 
Description: 

Activating the immune system to eradicate cancer.  Focuses on regulatory T cells.

Forty Seven

Business Area(s): 
Description: 

Committed to the advancement of immuno-oncology through the engagement of new and complementary phagocytic pathways that enhance anti-tumor efficacy and selectivity.

Geneius Biotechnology

Business Area(s): 
Description: 

Immuno-oncology targeting

Gilead

Business Area(s): 
Description: 

Research and development programs currently focus on potential treatments in HIV/AIDS, liver diseases, hematology and oncology, inflammatory and respiratory diseases, and cardiovascular conditions ...

Gradalis

Business Area(s): 
Description: 

Cancer immunotherapy.  

IFM Therapeutics

Business Area(s): 
Description: 

Immune Design

Business Area(s): 
Description: 

Advancing first-in-class immunotherapy product candidates in oncology, as well as infectious and allergic diseases.

Incyte

Business Area(s): 
Description: 

Our scientific innovation is based on a unique competency in medicinal chemistry, which is seamlessly integrated into a discovery process that is tailored to individual program needs. We have ...

Inovio Pharmaceuticals

Business Area(s): 
Description: 

Develops DNA vaccines and antigen-targeting immunotherapy to treat cancer and viral infections.

Jounce Therapeutics

Business Area(s): 
Description: 

Cancer Immunotherapies

Juno Therapeutics

Business Area(s): 
Description: 

The company leverages two technologies—CARs and TCRs—to activate a patient’s own T cells so that they attack cancer cells. Through genetic engineering, we insert a gene for a particular CAR or TCR ...

Kineta

Business Area(s): 
Description: 

Develops novel immune-modulating therapeutics and vaccine adjuvants targeting autoimmune and infectious diseases.  Our research is focused on developing novel immune modulating therapies in ...

Kite Pharma

Business Area(s): 
Description: 

Kite Pharma is developing engineered autologous T cells that express either a chimeric antigen receptor (CAR) or a T cell receptor (TCR), depending on the type of cancer. The platform has the ...

Light Sciences Oncology

Business Area(s): 
Description: 

Talaporfin Sodium for solid tumors

Lion Biotechnologies

Business Area(s): 
Description: 

Develops tumor-infiltrating T cells designed to overcome the immunosuppressive effects of cancer, while leveraging and enhancing the power of TILs to treat, and potentially cure, all solid tumors ...

MacroGenics

Business Area(s): 
Description: 

A clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, autoimmune disorders and infectious ...

Merck

Business Area(s): 
Description: 

Small Molecules and therapeutics.

MTG Biotherapeutics

Business Area(s): 
Description: 

Immuno-oncology cancer treatment

NantKwest

Business Area(s): 
Description: 

Develops immunotherapeutics that activate natural killer cells.  

Nativis

Business Area(s): 
Description: 

Makes a non-invasive device for cancer treatment.  The device emits a low-level, non-thermal, non-ionizing radio frequency energy (RFE) for disrupting cell division in cancer.

NewLink Genetics

Business Area(s): 
Description: 

Develops immuno-oncology therapeutics.

OncoGenex Pharmaceuticals

Business Area(s): 
Description: 

Develops novel therapeutics that target important mechanisms of treatment resistance in cancer.

OncoResponse

Business Area(s): 
Description: 

Uses the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of antibody-derived therapeutics to treat cancer.

Oncotherapy Solutions

Business Area(s): 
Description: 

Develops novel, potent and safer drug conjugates carrying new chemotherapeutic agents.

Potenza Therapeutics

Business Area(s): 
Description: 

Potenza Therapeutics is a biotechnology company focused on building a diverse portfolio of oncology programs that utilize the body's own immune system to seek out, recognize and destroy tumors ...

RJS Biologics

Business Area(s): 
Description: 

Cancer Drug Delivery Technology - enhances drug delivery with small molecule affinity-tethering compounds

Seattle Genetics

Business Area(s): 
Description: 

The company produces antibody-based drugs, many are used to treat cancer.